Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors a novel mechanism not shared by any currently licensed UK weight management medicine
If you have already achieved significant weight loss and are in a maintenance phase, you may be able to reduce your dose to a level that is more affordable at out-of-pocket prices
GLP-1 expression was downregulated in wild-type Lox5 cells knocked out by FNDC5, and the induced expression of lipolysis and autophagy-related genes and proteins were also inhibited, such as adipose triacylglyceride lipase (ATGL), hormone-sensitive lipase (HSL), and hepatic lipase deficiency gene (LIPC)
This can only be partially attributed to weight loss [21] reported a weight-independent effect of GIP receptor stimulation on insulin sensitivity
Weight loss independently improves blood sugar levels
People choose Trulicity because it is a once-weekly injection that reduces daily treatment burden, supports steady blood sugar management across the week, works alongside existing diabetic care plans, and features an easy-to-use pre-filled pen design
